Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: January 10, 2006
Last updated: May 31, 2012
Last verified: February 2011